Climb Bio, Inc. CLYM GB — Net Income Loss
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Climb Bio, Inc.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s gb — net income loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s GB — net income loss?
- Climb Bio, Inc. (CLYM) reported GB — net income loss of -$68K in Q4 2025.
- How has Climb Bio, Inc.'s GB — net income loss changed year-over-year?
- Climb Bio, Inc.'s GB — net income loss increased by 96.0% year-over-year, from -$1.69M to -$68K.
- What is the long-term trend for Climb Bio, Inc.'s GB — net income loss?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s GB — net income loss has grown at a -70.1% compound annual growth rate (CAGR), from -$34.17M to -$272K.
- What does GB — net income loss mean?
- This metric represents the net profit or loss generated by the specific business segment or geographic region after accounting for all allocated operating expenses and costs. It serves as a key indicator of the segment's financial viability and its contribution to the overall bottom line of the organization. Monitoring this figure helps stakeholders evaluate the operational efficiency and profitability trends of the segment over time.